Chemed Corporation (NYSE: CHE) reported Q3 EPS of $5.64, $0.12 worse than the analyst estimate of $5.76. Revenue for the quarter came in at $606.2 million versus the consensus estimate of $608.25 million.

GUIDANCE:

Chemed Corporation sees FY2024 EPS of $23.00-$23.15, versus the consensus of $23.56.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.